Last reviewed · How we verify
NCT04742257: RECOVER
Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb Spasticity
NA trial testing MyoRegulator® device in Muscle Spasticity in 28 participants. Terminated before completion.
30 June 2024
Quick facts
| Lead sponsor | PathMaker Neurosystems Inc. |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 28 |
| Start date | 4 March 2022 |
| Primary completion | 30 June 2024 |
| Estimated completion | 30 June 2024 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- MyoRegulator® device
Conditions studied
- Muscle Spasticity — all drugs for Muscle Spasticity →
- Stroke — all drugs for Stroke →
Sponsor
PathMaker Neurosystems Inc. — full company profile →
Who can join
Adults 18 to 85, any sex, with Muscle Spasticity or Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a multi-center, randomized, double-blind (patient and evaluator), sham-controlled study to be conducted in stroke patients with upper-extremity spasticity. The main objectives of this study are to evaluate the performance and safety of the MyoRegulator® device in active- versus sham-treated patients after 5 consecutive days of treatment. The MyoRegulator® device is a non-significant risk (NSR) investigational non-invasive neuromodulation device that uses multi-site direct current (multi-site DCS) stimulation for the treatment of muscle spasticity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04742257
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Muscle Spasticity
Currently open trials in the same condition.
- NCT07118228 — Ultrasonographic Assessment of Muscle Morphology, Function, and Clinical Findings in Spastic Cerebral Palsy · recruiting
- NCT06674785 — SIRS-ESWT Trial: Shoulder Internal Rotator Spasticity Trial Treated With Extracorporeal Shock Wave Therapy Trial · NA · recruiting
- NCT06902168 — Effect of Diving and Aquatic Exercises on Muscle Spasticity and Motor Function in Children With Spastic Cerebral Palsy · NA · recruiting
- NCT06733025 — Comparing Upper Limb Surgery and Botulinum Toxin for Spasticity: A Paired Design Study · NA · recruiting
- NCT06536751 — Therapeutic Photobiomodulation and Tretament of Spasticity · Phase 2, PHASE3 · recruiting
Other PathMaker Neurosystems Inc. trials
Trials by the same sponsor.
- NCT06165172 — Early Feasibility Study of the MyoRegulator® for Treatment of ALS · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04742257 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PathMaker Neurosystems Inc.
- Last refreshed: 15 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04742257.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing